Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial.

Autor: Karyana, Muhammad1 (AUTHOR) mkaryana@ina-respond.net, Djaharuddin, Irawaty2 (AUTHOR), Rif'ati, Lutfah1 (AUTHOR), Arif, Mansyur3 (AUTHOR), Choi, Mi Kyung4 (AUTHOR), Angginy, Nova5 (AUTHOR), Yoon, Aeri4 (AUTHOR), Han, Jumi4 (AUTHOR), Josh, Fonny3 (AUTHOR), Arlinda, Dona1 (AUTHOR), Narulita, Asvin3 (AUTHOR), Muchtar, Faisal3 (AUTHOR), Bakri, Rizki Auliah3 (AUTHOR), Irmansyah, s1 (AUTHOR)
Zdroj: Stem Cell Research & Therapy. 4/1/2022, Vol. 13 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje